Osmotica Corp.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Osmotica Corp..The latest application filed is for "triple combination release multi-layered tablet".

Company Profile

0.17.4

Osmotica Corp. - Tortola VG
OSMOTICA CORP. - Alfaro Ferrer Ramirez, R.G. Hodge Plaza, 2nd Flr Tortola VG
Osmotica Corp. - Road Town VG
Osmotica Corp - Tortola VG

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Laser drilling system and method Grant 7,569,794 - Faour , et al. August 4, 2	2009-08-04
Triple Combination Release Multi-Layered Tablet App 20080299197 - Toneguzzo; Fernando G. ; et al.	2008-12-04
Delivery device containing venlafaxine and memantine and method of use thereof App 20080175909 - VERGEZ; Juan A. ; et al.	2008-07-24
Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid App 20080175872 - Abalo; Esteban A. ; et al.	2008-07-24
Ophthalmic Solutions App 20080050335 - FAOUR; Joaquina ; et al.	2008-02-28
Drug delivery device containing neuraminidase inhibitor and an H1 antagonist Grant 7,208,176 - Faour , et al. April 24, 2	2007-04-24
Osmotic device containing pseudoephedrine and an H1 antagonist Grant 7,147,870 - Faour , et al. December 12, 2	2006-12-12
Multi-layered osmotic device Grant RE39,069 - Faour , et al. April 18, 2	2006-04-18
Osmotic device containing venlafaxine and an anti-psychotic agent Grant 7,008,641 - Faour , et al. March 7, 2	2006-03-07
Laser drilling system and method Grant 6,809,288 - Faour October 26, 2	2004-10-26
Combined diffusion/osmotic pumping drug delivery system Grant 6,753,011 - Faour June 22, 2	2004-06-22
Pharmaceutical composition containing mosapride and pancreatin Grant 6,676,933 - Vergez , et al. January 13, 2	2004-01-13
Osmotic device containing pseudoephedrine and an H1 antagonist Grant 6,613,357 - Faour , et al. September 2, 2	2003-09-02
Drug delivery device containing oseltamivir and an H1 antagonist Grant 6,605,302 - Faour , et al. August 12, 2	2003-08-12
Osmotic device containing alprazolam and an antipsychotic agent Grant 6,599,532 - Faour , et al. July 29, 2	2003-07-29
Osmotic device having a preformed passageway that increases in size Grant 6,599,284 - Faour July 29, 2	2003-07-29
Osmotic device containing venlafaxine and an anti-psychotic agent Grant 6,572,890 - Faour , et al. June 3, 2	2003-06-03
Osmotic device containing diltiazem and an ACE inhibitor or diuretic Grant 6,569,456 - Faour , et al. May 27, 2	2003-05-27
Osmotic device containing ranitidine and a prokinetic agent Grant 6,521,255 - Vergez , et al. February 18, 2	2003-02-18
Osmotic device within an osmotic device Grant 6,491,949 - Faour , et al. December 10, 2	2002-12-10
Combined diffusion/osmotic pumping drug delivery system Grant 6,352,721 - Faour March 5, 2	2002-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.